NCT01599169View on ClinicalTrials.gov

Evaluation of the Efficacy and Tolerance of B-Back® on the Burnout Syndrome

NACompletedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Efficacy and Tolerance of B-Back® on the Burnout Syndrome
Interventions
DIETARY_SUPPLEMENT

Dietary supplement : B-Back® (α-casozepine, taurine, eleutherococcus senticosus, Extramel)

2 tablets/day after breakfast during 12 weeks

DIETARY_SUPPLEMENT

B-Back® placebo (without active compounds)

2 tablets/day after breakfast during 12 weeks

Trial Locations (1)

Unknown

Cinical Pharmacology Department - Université Victor Segalen Bordeaux 2, Bordeaux

All Listed Sponsors
collaborator

Nanox International Laboratory (Belgique)

UNKNOWN

lead

Université Victor Segalen Bordeaux 2

OTHER

NCT01599169 - Evaluation of the Efficacy and Tolerance of B-Back® on the Burnout Syndrome | Biotech Hunter | Biotech Hunter